Jubilant Pharmova Ltd

NSE: JUBLPHARMA · BSE: 530019 · Pharmaceuticals & Biotechnology · 29 announcements

Share price: ₹974.60
Market cap: ₹15,524 Cr
Revenue (annual): ₹8,280 Cr
Net profit (annual): ₹398.5 Cr
P/E (TTM): 44.1×Sector 47.3×
Promoter holding: 47.68%+0.00% QoQ
FII holding: 15.87%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Legal & Regulatory 6 Annual General Meeting 4 Other Announcement 3 Financial Results 3 Board Meeting Outcome 3 Results Update 2 Business Update 2 Production Started 1 Management Change 1 Employee Stock Options 1 Earnings Call 1 Dividend 1 Board Meeting Date 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

22 May 2026 14:39 IST NSE

Management Change

Jubilant Pharmova Management Change

Jubilant Pharmova appointed Ashish Mukkirwar as CFO effective May 23, 2026. He succeeds Arun Kumar Sharma, who transitions to an advisory role following his resignation.

Read the filing ↗